Skip to main content
Top
Published in: Rheumatology International 5/2016

01-05-2016 | Original Article - Observational Research

Systemic sclerosis and silica exposure: a rare association in a large Brazilian cohort

Authors: Luiza F. Rocha, Ana Paula Luppino Assad, Roberta G. Marangoni, Ana Paula Toledo Del Rio, João Francisco Marques-Neto, Percival D. Sampaio-Barros

Published in: Rheumatology International | Issue 5/2016

Login to get access

Abstract

The objective of this study is to describe the characteristics of patients with Erasmus syndrome (ES) in a large SSc Brazilian cohort. Nine hundred and forty-seven SSc patients attended at the Scleroderma Outpatient Clinic at two academic medical centers in Brazil and classified as SSc according to the ACR/EULAR criteria were retrospectively studied. Information on demographics, clinical, and laboratory features was obtained by chart review. ES patients had their HLA class II characterized by PCR-SSO method as available. Among the 947 SSc patients studied, nine (0.9 %) had ES. These ES patients were predominantly male (78 %) and smokers (68 %) and presented diffuse SSc (67 %). Mean time of occupational exposure to silica was 13.7 years, with mean age at onset of 47 years. Previous history of tuberculosis was referred by 33 % of the ES patients. All the ES patients presented Raynaud’s phenomenon, esophageal involvement, and interstitial lung disease (ILD). Antinuclear antibodies were present in all the ES patients, while anti-topoisomerase I was positive in 44 % and no patient had anticentromere antibody. Three different HLA-DQB alleles (0506, 0305, and 0303) were observed. Compared to non-ES cases, patients with ES were associated with male gender (p < 0.001), diffuse SSc (p < 0.05), ILD (p < 0.05), positive anti-topoisomerase I antibodies (p < 0.05), and death (p < 0.05). Multivariate analysis did not confirm that silicosis is an independent risk factor for SSc. To conclude, ES was rare in this large SSc cohort, although associated with a bad prognosis.
Literature
2.
3.
go back to reference Dospinescu P, Jones GT, Basu N (2013) Environmental risk factors in systemic sclerosis. Curr Opin Rheumatol 25:179–183CrossRefPubMed Dospinescu P, Jones GT, Basu N (2013) Environmental risk factors in systemic sclerosis. Curr Opin Rheumatol 25:179–183CrossRefPubMed
4.
go back to reference Makol A, Reilly MJ, Rosenman KD (2011) Prevalence of connective tissue disease in silicosis (1985–2006): a report from the state of Michigan surveillance system for silicosis. Am J Ind Med 54:255–262CrossRefPubMed Makol A, Reilly MJ, Rosenman KD (2011) Prevalence of connective tissue disease in silicosis (1985–2006): a report from the state of Michigan surveillance system for silicosis. Am J Ind Med 54:255–262CrossRefPubMed
5.
go back to reference Erasmus LD (1957) Scleroderma in gold miners on the Witwatersrand with particular reference to pulmonary manifestations. S Afr J Lab Clin Med 3:209–231PubMed Erasmus LD (1957) Scleroderma in gold miners on the Witwatersrand with particular reference to pulmonary manifestations. S Afr J Lab Clin Med 3:209–231PubMed
6.
go back to reference Sluis-Cremer GK, Hessel PA, Nizdo EH, Churchill AR, Zeiss EA (1985) Silica, silicosis, and progressive systemic sclerosis. Br J Ind Med 42:838–843PubMedPubMedCentral Sluis-Cremer GK, Hessel PA, Nizdo EH, Churchill AR, Zeiss EA (1985) Silica, silicosis, and progressive systemic sclerosis. Br J Ind Med 42:838–843PubMedPubMedCentral
7.
go back to reference Rustin MH, Bull HA, Ziegler V, Mehlhorn J, Haustein UF, Maddison PJ et al (1990) Silica-associated systemic sclerosis in clinically, serologically and immunologically indistinguishable from idiopathic systemic sclerosis. Br J Dermatol 123:725–734CrossRefPubMed Rustin MH, Bull HA, Ziegler V, Mehlhorn J, Haustein UF, Maddison PJ et al (1990) Silica-associated systemic sclerosis in clinically, serologically and immunologically indistinguishable from idiopathic systemic sclerosis. Br J Dermatol 123:725–734CrossRefPubMed
8.
go back to reference Sanchez-Roman J, Wichmann I, Salaberri J, Varela JM, Nuñez-Roldan A (1953) Multiple clinical and biological autoimmune manifestations in 50 workers after occupational exposure to silica. Ann Rheum Dis 52:534–538CrossRef Sanchez-Roman J, Wichmann I, Salaberri J, Varela JM, Nuñez-Roldan A (1953) Multiple clinical and biological autoimmune manifestations in 50 workers after occupational exposure to silica. Ann Rheum Dis 52:534–538CrossRef
9.
go back to reference Bovenzi M, Barbone F, Betta A, Tommasini M, Versini W (1995) Scleroderma and occupational exposure. Scand J Work Environ Health 21:289–292CrossRefPubMed Bovenzi M, Barbone F, Betta A, Tommasini M, Versini W (1995) Scleroderma and occupational exposure. Scand J Work Environ Health 21:289–292CrossRefPubMed
10.
go back to reference Koeger AC, Lang T, Alcaix D, Milleron B, Rosenberg S, Chaibi P et al (1995) Silica-associated connective tissue disease: a study of 24 cases. Medicine (Baltimore) 74:221–237CrossRef Koeger AC, Lang T, Alcaix D, Milleron B, Rosenberg S, Chaibi P et al (1995) Silica-associated connective tissue disease: a study of 24 cases. Medicine (Baltimore) 74:221–237CrossRef
11.
go back to reference Diot E, Lesire V, Guilmot JL, Metzger MD, Pilore R, Rogier S et al (2002) Systemic sclerosis and occupational risk factors: a case-control study. Occup Environ Med 59:545–549CrossRefPubMedPubMedCentral Diot E, Lesire V, Guilmot JL, Metzger MD, Pilore R, Rogier S et al (2002) Systemic sclerosis and occupational risk factors: a case-control study. Occup Environ Med 59:545–549CrossRefPubMedPubMedCentral
12.
go back to reference Miranda AA, Nascimento AC, Peixoto IL, Scrignoli JA, Cardoso MS, Ribeiro SL (2013) Erasmus syndrome: silicosis and systemic sclerosis. Braz J Rheumatol 53:310–313 Miranda AA, Nascimento AC, Peixoto IL, Scrignoli JA, Cardoso MS, Ribeiro SL (2013) Erasmus syndrome: silicosis and systemic sclerosis. Braz J Rheumatol 53:310–313
13.
go back to reference Marie I, Gehano J-F, Bubenheim M, Duval-Modeste AB, Joly P, Dominique S et al (2014) Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature. Autoimmun Rev 13:151–156CrossRefPubMed Marie I, Gehano J-F, Bubenheim M, Duval-Modeste AB, Joly P, Dominique S et al (2014) Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature. Autoimmun Rev 13:151–156CrossRefPubMed
14.
go back to reference Van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A et al (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheumatol 65:2737–2747CrossRef Van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A et al (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheumatol 65:2737–2747CrossRef
15.
go back to reference Clements PJ, Lachenbruch PA, Seibold JR, Zee B, Steen VD, Brennan P et al (1993) Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 20:1892–1896PubMed Clements PJ, Lachenbruch PA, Seibold JR, Zee B, Steen VD, Brennan P et al (1993) Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 20:1892–1896PubMed
16.
go back to reference Silman AJ, Jones S (1992) What is the contribution of occupational environmental factors to the occurrence of scleroderma in men. Ann Rheum Dis 51:1322–1324CrossRefPubMedPubMedCentral Silman AJ, Jones S (1992) What is the contribution of occupational environmental factors to the occurrence of scleroderma in men. Ann Rheum Dis 51:1322–1324CrossRefPubMedPubMedCentral
17.
go back to reference Burns CJ, Liang TJ, Gillespie BW, Heeringa SG, Alcser KH, Mayes MD et al (1996) The epidemiology of scleroderma among women: assessment of risk from exposure to silicone and silica. J Rheumatol 23:1904–1911PubMed Burns CJ, Liang TJ, Gillespie BW, Heeringa SG, Alcser KH, Mayes MD et al (1996) The epidemiology of scleroderma among women: assessment of risk from exposure to silicone and silica. J Rheumatol 23:1904–1911PubMed
18.
go back to reference Rosenman KD, Moore-Fuller M, Reilly MJ (1999) Connective tissue disease and silicosis. Am J Ind Med 35:375–381CrossRefPubMed Rosenman KD, Moore-Fuller M, Reilly MJ (1999) Connective tissue disease and silicosis. Am J Ind Med 35:375–381CrossRefPubMed
19.
go back to reference Englert H, Small-McMahon J, Davis K, O’Connor H, Chambers P, Brooks P (2000) Male systemic sclerosis and occupational silica exposure—a population-based study. Aust NZ J Med 30:215–220CrossRef Englert H, Small-McMahon J, Davis K, O’Connor H, Chambers P, Brooks P (2000) Male systemic sclerosis and occupational silica exposure—a population-based study. Aust NZ J Med 30:215–220CrossRef
20.
go back to reference Marie I, Menard JF, Duval-Modeste AB, Joly P, Dominique S, Bravard P et al (2015) Association of occupational exposure with features of systemic sclerosis. J Am Acad Dermatol 72:456–464CrossRefPubMed Marie I, Menard JF, Duval-Modeste AB, Joly P, Dominique S, Bravard P et al (2015) Association of occupational exposure with features of systemic sclerosis. J Am Acad Dermatol 72:456–464CrossRefPubMed
21.
go back to reference Magnant J, Monte M, Guilmot J-L, Lasfargues G, Diot P, Asquier D et al (2005) Relationship between occupational risk factors and severity markers in systemic sclerosis. J Rheumatol 32:1713–1718PubMed Magnant J, Monte M, Guilmot J-L, Lasfargues G, Diot P, Asquier D et al (2005) Relationship between occupational risk factors and severity markers in systemic sclerosis. J Rheumatol 32:1713–1718PubMed
23.
go back to reference Ueki A, Isozaki Y, Tomokuni A, Ueki H, Kusaka M, Tanaka S et al (2001) Different distribution of HLA class II alleles in anti-topoisomerase I auto-antibody responders between silicosis and systemic sclerosis patients, with a common distinct amino acid sequence in the HLA-DQB1 domain. Immunology 204:458–465 Ueki A, Isozaki Y, Tomokuni A, Ueki H, Kusaka M, Tanaka S et al (2001) Different distribution of HLA class II alleles in anti-topoisomerase I auto-antibody responders between silicosis and systemic sclerosis patients, with a common distinct amino acid sequence in the HLA-DQB1 domain. Immunology 204:458–465
24.
go back to reference Furukawa H, Oka S, Shimada K, Tsuchiya N, Thoma S (2015) Genetics of interstitial lung disease: Vol de nuit (Night flight). Clin Med Insights Circ Respir Pulm Med 29(9):1–7 Furukawa H, Oka S, Shimada K, Tsuchiya N, Thoma S (2015) Genetics of interstitial lung disease: Vol de nuit (Night flight). Clin Med Insights Circ Respir Pulm Med 29(9):1–7
25.
go back to reference Del Rio AP, Sachetto Z, Sampaio-Barros PD, Marques-Neto JF, Londe AC, Bertolo MB (2013) HLA markers for poor prognosis in systemic sclerosis Brazilian patients. Dis Markers 35:73–78CrossRefPubMedPubMedCentral Del Rio AP, Sachetto Z, Sampaio-Barros PD, Marques-Neto JF, Londe AC, Bertolo MB (2013) HLA markers for poor prognosis in systemic sclerosis Brazilian patients. Dis Markers 35:73–78CrossRefPubMedPubMedCentral
26.
go back to reference Rosenman KD, Reilly MJ, Rice C, Hertzberg V, Tseng CY, Anderson HA (1998) Silicosis among foundry workers. Implication for the need to revise the OSHA standard. Am J Epidemiol 144:890–900CrossRef Rosenman KD, Reilly MJ, Rice C, Hertzberg V, Tseng CY, Anderson HA (1998) Silicosis among foundry workers. Implication for the need to revise the OSHA standard. Am J Epidemiol 144:890–900CrossRef
27.
go back to reference McHugh NJ, Whyte J, Harvey G, Haustein UF (1994) Anti-topoisomerase I antibodies in silica-associated systemic sclerosis. A model for autoimmunity. Arthritis Rheumatol 37:1198–1205CrossRef McHugh NJ, Whyte J, Harvey G, Haustein UF (1994) Anti-topoisomerase I antibodies in silica-associated systemic sclerosis. A model for autoimmunity. Arthritis Rheumatol 37:1198–1205CrossRef
28.
go back to reference Rees D, Murray J (2007) Silica, silicosis and tuberculosis. Int J Tuberc Lung Dis 11:474–484PubMed Rees D, Murray J (2007) Silica, silicosis and tuberculosis. Int J Tuberc Lung Dis 11:474–484PubMed
29.
go back to reference Sampaio-Barros PD, Bortoluzzo AB, Marangoni RG, Rocha LF, Del Rio AP, Samara AM et al (2012) Survival, causes of death, and prognostic factors in systemic sclerosis: analysis of 947 Brazilian patients. J Rheumatol 39:1971–1978CrossRefPubMed Sampaio-Barros PD, Bortoluzzo AB, Marangoni RG, Rocha LF, Del Rio AP, Samara AM et al (2012) Survival, causes of death, and prognostic factors in systemic sclerosis: analysis of 947 Brazilian patients. J Rheumatol 39:1971–1978CrossRefPubMed
Metadata
Title
Systemic sclerosis and silica exposure: a rare association in a large Brazilian cohort
Authors
Luiza F. Rocha
Ana Paula Luppino Assad
Roberta G. Marangoni
Ana Paula Toledo Del Rio
João Francisco Marques-Neto
Percival D. Sampaio-Barros
Publication date
01-05-2016
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 5/2016
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-015-3412-0

Other articles of this Issue 5/2016

Rheumatology International 5/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.